Specifically, it represents a true opportunity to greatly increase access to radical cure of P. vivax malaria, and thus support malaria elimination, and provides an opportunity to address a gender gap in our understanding of G6PD epidemiology and its clinical implications. This evidence concerns the gene G6PD and malaria.